Size labelling of surgical bioprostheses: implications for TAV-in-SAV

TAVI within failing surgical aortic bioprostheses

When novel techniques are considered in the treatment of high risk patients who already underwent surgical aortic valve replacement (SAVR) and are facing a bioprosthetic valve failure a detailed imaging approach is crucial. Recognising bioprosthetic valve design and relevant anatomical details, along with the evaluation of coexisting risk factors for adverse effects during TAV-in-SAV procedure, are the main goals of this chapter as we explore what “Heart Team” needs to know.